Deepa Dongarwar

Ms. Deepa Dongarwar

Baylor College of Medicine, Houston, Texas, USA
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2019 in Journal of Pediatric and Adolescent Gynecology
Verified
Journal Article
Closed access
DDDeepa Dongarwar
Deepa Dongarwar
HSHamisu Mohammed Salihu
Hamisu Mohammed Salihu

6 December 2019 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Closed access
PDF file
HSHamisu M. Salihu
Hamisu M. Salihu
DDDeepa Dongarwar
Deepa Dongarwar
LKLindsey M. King
Lindsey M. King
KYKorede K. Yusuf
Korede K. Yusuf
Sahra IbrahimiSahra Ibrahimi
Sahra Ibrahimi
ASAbraham Salinas
Abraham Salinas

28 March 2022 in Systems Biology in Reproductive Medicine
Verified
Journal Article
Closed access
DDDeepa Dongarwar
Deepa Dongarwar
VMVicki Mercado
Vicki Mercado
SASylvia Adu-Gyamfi
Sylvia Adu-Gyamfi
MLMei-Li Laracuente
Mei-Li Laracuente
HSHamisu M. Salihu
Hamisu M. Salihu
With delayed child-bearing age, there has been an increase in infertility rates globally and in the United States (US). Unsurprisingly, there has been a concomitant substantial increase in the number of individuals seeking infertility treatments over the last decade. This study aimed to examine the relationship between race/ethnicity and the utilization of different infertility treatments over the previous decade. We conducted this retrospective cohort study using the United States (US) Birth data files 2011–2019. We calculated the rates of infertility treatment and its subtypes over the study period. Descriptive statistics were utilized to examine the sociodemographic and birth characteristics for overall births and those associated with any infertility treatment and each of its subtypes. We calculated the level of association between race/ethnicity and utilization of infertility treatment and the subtypes using adjusted logistic regression models. We found that the rate of infertility treatments for all subtypes considered, had steadily increased by 63.7% within the past decade. In contrast, fertility enhancing drugs or Intrauterine Insemination (IUI) increased by 134%, and in vitro fertilization (IVF), gamete intrafallopian transfer (GIFT), and zygote intrafallopian transfer (ZIFT) treatments increased by 40% over the 9-year study period. Non-Hispanic (NH) Asian women had the highest rate of any infertility treatment with a rate of 25 per 1000 births whereas Hispanic women had the lowest rate of any infertility treatment at 5.8 per 1000 births. When compared with NH-White women, NH-Asian women had a modest 7% lower likelihood (OR = 0.93, 95% CI = 0.92–0.94) of receiving any infertility treatment while NH-Black and Hispanic women had about 70% lower likelihood of receiving any infertility treatment. Our report of increased assisted reproductive technology (ART) utilization rates, and marked racial/ethnic differences in ART utilization highlight the importance of expanding knowledge of inequities that continue to impact marginalized groups, a critical step for informing actionable strategy formulations (i.e., advocacy, policy change, patient education, provider training) to address these inequities.

1 May 2020 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
ABAngela P.H. Burgess
Angela P.H. Burgess
DDDeepa Dongarwar
Deepa Dongarwar
ZSZachary Spigel
Zachary Spigel
HSHamisu M. Salihu
Hamisu M. Salihu
AMAmirhossein Moaddab
Amirhossein Moaddab
KFKarin Fox
Karin Fox

1 September 2019 in Archives of Physical Medicine and Rehabilitation
Verified
Journal Article
Closed access
FSFelicia Skelton
Felicia Skelton
Jason Lee SalemiJason Lee Salemi
Jason Lee Salemi
LALois Akpati
Lois Akpati
SSSused Silva
Sused Silva
DDDeepa Dongarwar
Deepa Dongarwar
HSHamisu M. Salihu
Hamisu M. Salihu

20 July 2020 in International Journal of Maternal and Child Health and Aids
Verified
Journal Article
Open access
DDDeepa Dongarwar
Deepa Dongarwar
VAVeronica B. Ajewole
Veronica B. Ajewole
EOEmmanuella Oduguw
Emmanuella Oduguw
ANAhone Ngujede
Ahone Ngujede
KHKiydra Harris
Kiydra Harris
HSHamisu M. Salihu
Hamisu M. Salihu
We present a conceptual model that describes the social determinants of health (SDOH) pathways contributing to worse outcomes in minority maternal and child health (MCH) populations due to the current COVID-19 pandemic. We used International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10) codes in the categories Z55-Z65 to identify SDOH that potentially modulate MCH disparities. These SDOH pathways, coupled with pre-existing comorbidities, exert higher-than-expected burden of maternal-fetal morbidity and mortality in minority communities. There is an urgent need for an increased infusion of resources to mitigate the effects of these SDOH and avert permanent truncation in quality and quantity of life among minorities following the COVID-19 pandemic. Key words: • COVID-19 • Maternal and child health disparity • Social determinants of health • Minority women Copyright © 2020 Dongarwar et al. Published by Global Health and Education Projects, Inc. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in this journal, is properly cited.